INTRODUCTIONTakayasu arteritis (TA) is a relatively uncommon chronic nonspecific inflammatory disease of unknown etiology that mainly affects the aorta and its major branches . The inflammatory process creates structural changes that lead to wall thickening, fibrosis, and stenosis . Stenosis is the most common vascular lesion of TA , and significant stenotic lesions of the distal thoracic or abdominal aorta may result in middle aortic syndrome (MAS) , which manifests as lower limb ischemia, hypertension, myocardial hypertrophy, heart failure, hemorrhagic stroke , or even death. Historically, the management of such lesions involved with TA has been that of anti‐inflammatory therapy and open surgical techniques. However, the open surgical approach is technically challenging due to its complexity with multiple vessel involvement and is associated with high rates of procedural and periprocedural complications, such as postoperative anastomotic aneurysm formation, and graft occlusion . Due to these challenges, percutaneous transluminal angioplasty (PTA) has gained popularity as the preferred treatment method in suitable patients . However, major concerns such as obstructive dissection and long‐term patency along with PTA alone still exist . Hence, some case reports and retrospective studies evaluated the feasibility of stenting for the treatment of this condition. However, related data
Catheterization and Cardiovascular Interventions – Wiley
Published: Jan 15, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera